Showing results (1581-1590 of 1,955) with videos related to
Sort By:
Pageof 196
Haematologica|January 18, 2024
Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapyAung M Tun, Yucai Wang, Seth Maliske, et al.BMC Cancer|February 17, 2016
Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplificationJieyi Wang, Liliane Goetsch, Lora Tucker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2022
CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 StudyBenoit You, Vasudha Sehgal, Balakrishna Hosmane, et al.Bone Marrow Transplantation|April 11, 2006
Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemiaM A Elliott, A Tefferi, W J Hogan, et al.Blood|May 3, 2002
Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasiaAyalew Tefferi, Ruben A Mesa, Leigh A Gray, et al.Journal of Abnormal Psychology|November 11, 2009
The stability of personality traits in individuals with borderline personality disorderChristopher J Hopwood, Daniel A Newman, M Brent Donnellan, et al.Mayo Clinic Proceedings|February 13, 2004
Therapeutic options in patients with lymphoma and severe liver dysfunctionIrene M Ghobrial, Robert C Wolf, Denise L Pereira, et al.Transplantation and Cellular Therapy|May 13, 2022
Longitudinal Patient Reported Outcomes with CAR-T Cell Therapy Versus Autologous and Allogeneic Stem Cell TransplantSurbhi Sidana, Amylou C Dueck, Gita Thanarajasingam, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 22, 2018
Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191Haiwen Ni, Fazal Shirazi, Veerabhadran Baladandayuthapani, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2018
Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US CohortsClémentine Sarkozy, Matthew J Maurer, Brian K Link, et al.Pageof 196